1-5 of 5
Diane E. Hasz
Close
Sort by
Journal Articles

β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice

Andrew Kim, Kelly Morgan, Diane E. Hasz, Stephen M. Wiesner, Jennifer O. Lauchle, Jennifer L. Geurts, Miechaleen D. Diers, Doan T. Le, Scott C. Kogan, Luis F. Parada, Kevin Shannon, David A. Largaespada
Journal: Blood
Blood (2006) 109 (4): 1687–1691.
https://doi.org/10.1182/blood-2006-05-025395
Published: 2006
Includes: Supplemental data
Journal Articles

Repressible transgenic model of NRAS oncogene–driven mast cell disease in the mouse

Stephen M. Wiesner, Jamie M. Jones, Diane E. Hasz, David A. Largaespada
Journal: Blood
Blood (2005) 106 (3): 1054–1062.
https://doi.org/10.1182/blood-2004-08-3306
Published: 2005
Journal Articles

Expression Signature of Therapy Resistant AML: Use of In Vitro Selected Ara-C Resistant BXH-2 Strain AML Cell Lines.

Michaela Long Tsai, MD, Bin Yin, PhD, Diane E. Hasz, BS, David A. Largaespada, PhD
Journal: Blood
Blood (2004) 104 (11): 2032.
https://doi.org/10.1182/blood.V104.11.2032.2032
Published: 2004
Journal Articles

In Vivo Regulatable Mouse Models of NRAS(V12)-Driven Acute Systemic Mastocytosis and Acute Myeloid Leukemia.

Stephen M. Wiesner, B.S., Diane E. Hasz, B.S., Jamie M. Jones, David A. Largaespada, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3384.
https://doi.org/10.1182/blood.V104.11.3384.3384
Published: 2004
Journal Articles

In Vitro Derivation of ARA-C Resistant BXH-2 AML Cell Lines: Association of RAS/MAPK and P53-Regulated Pathways with Chemoresistance.

Bin Yin, Ph.D., Diane E. Hasz, B.S., Won-Il Kim, B.S., Zhengwei Mao, B.S., David A. Largaespada, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 4384.
https://doi.org/10.1182/blood.V104.11.4384.4384
Published: 2004